Protalix BioTherapeutics, Inc. (PLX) Debt Components
- 2020-12-31: Notes Payable, CurrentUSD $4.09M; Long-term Debt, Excluding Current MaturitiesUSD (m); Debt Instrument, Face AmountUSD (m); Debt Instrument, Interest Rate, Stated Percentagepure (m).
- 2020-09-30: Notes Payable, CurrentUSD $4.30M; Long-term Debt, Excluding Current MaturitiesUSD (m); Debt Instrument, Face AmountUSD (m); Debt Instrument, Interest Rate, Stated Percentagepure (m).
- 2020-06-30: Notes Payable, CurrentUSD $4.30M; Long-term Debt, Excluding Current MaturitiesUSD (m); Debt Instrument, Face AmountUSD (m); Debt Instrument, Interest Rate, Stated Percentagepure (m).
- 2020-03-31: Notes Payable, CurrentUSD $4.30M; Long-term Debt, Excluding Current MaturitiesUSD (m); Debt Instrument, Face AmountUSD (m); Debt Instrument, Interest Rate, Stated Percentagepure (m).
Protalix BioTherapeutics, Inc. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Notes Payable, Current USD | Long-term Debt, Excluding Current Maturities USD | Debt Instrument, Face Amount USD | Debt Instrument, Interest Rate, Stated Percentage pure | Debt Instrument, Convertible, Conversion Price USD/shares |
|---|---|---|---|---|---|
| 2020-12-31 | $4.09M | (m) | (m) | (m) | (m) |
| 2020-09-30 | $4.30M | (m) | (m) | (m) | (m) |
| 2020-06-30 | $4.30M | (m) | (m) | (m) | (m) |
| 2020-03-31 | $4.30M | (m) | (m) | (m) | (m) |
| 2019-12-31 | $4.30M | (m) | (m) | (m) | (m) |
| 2017-09-30 | (m) | (m) | (m) | 4.50% | (m) |
| 2014-12-31 | (m) | $912.00K | (m) | (m) | (m) |
| 2013-12-31 | (m) | $2.37M | (m) | (m) | (m) |
| 2013-09-18 | (m) | (m) | (m) | 4.50% | 5.76 |
| 2013-09-18 | (m) | (m) | $69.00M | (m) | (m) |
| 2013-06-30 | (m) | $376.00K | (m) | (m) | (m) |
| 2013-03-31 | (m) | $2.70M | (m) | (m) | (m) |
| 2012-12-31 | (m) | $5.42M | (m) | (m) | (m) |
| 2012-09-30 | (m) | $2.79M | (m) | (m) | (m) |
| 2012-06-30 | (m) | $4.68M | (m) | (m) | (m) |
| 2011-12-31 | (m) | $6.57M | (m) | (m) | (m) |
| 2011-09-30 | (m) | $4.74M | (m) | (m) | (m) |
| 2011-06-30 | (m) | $4.45M | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |